DocuSign, Inc. (NASDAQ:DOCU) Given Consensus Recommendation of “Hold” by Brokerages

Shares of DocuSign, Inc. (NASDAQ:DOCUGet Free Report) have earned an average recommendation of “Hold” from the thirteen ratings firms that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $60.15.

Several analysts have recently issued reports on DOCU shares. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $50.00 price objective on shares of DocuSign in a report on Friday, January 12th. Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $49.00 to $64.00 in a report on Tuesday, January 16th. Piper Sandler decreased their price target on DocuSign from $57.00 to $50.00 and set a “neutral” rating on the stock in a report on Friday, December 8th. JMP Securities restated a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a report on Monday, January 22nd. Finally, TheStreet upgraded DocuSign from a “d+” rating to a “c-” rating in a report on Tuesday, December 19th.

Check Out Our Latest Stock Analysis on DocuSign

Insider Transactions at DocuSign

In other news, CEO Allan C. Thygesen sold 7,420 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $58.19, for a total transaction of $431,769.80. Following the transaction, the chief executive officer now owns 119,447 shares of the company’s stock, valued at approximately $6,950,620.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Allan C. Thygesen sold 7,420 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $58.19, for a total transaction of $431,769.80. Following the transaction, the chief executive officer now owns 119,447 shares of the company’s stock, valued at approximately $6,950,620.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Stephen Shute sold 13,606 shares of the stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $61.30, for a total value of $834,047.80. Following the transaction, the insider now directly owns 5,480 shares in the company, valued at approximately $335,924. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 129,612 shares of company stock valued at $7,869,435. 17.80% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On DocuSign

Institutional investors have recently added to or reduced their stakes in the stock. Apollon Wealth Management LLC boosted its position in DocuSign by 6.9% during the second quarter. Apollon Wealth Management LLC now owns 5,788 shares of the company’s stock valued at $296,000 after purchasing an additional 372 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in DocuSign by 321.3% during the third quarter. Assenagon Asset Management S.A. now owns 214,877 shares of the company’s stock valued at $9,025,000 after purchasing an additional 163,875 shares in the last quarter. Grimes & Company Inc. bought a new stake in DocuSign during the third quarter valued at about $12,047,000. BI Asset Management Fondsmaeglerselskab A S boosted its position in DocuSign by 9.7% during the second quarter. BI Asset Management Fondsmaeglerselskab A S now owns 5,085 shares of the company’s stock valued at $260,000 after purchasing an additional 451 shares in the last quarter. Finally, Duality Advisers LP bought a new stake in DocuSign during the third quarter valued at about $1,686,000. Institutional investors own 77.96% of the company’s stock.

DocuSign Price Performance

Shares of DOCU opened at $61.61 on Friday. The stock has a market capitalization of $12.56 billion, a price-to-earnings ratio of 248.05, a price-to-earnings-growth ratio of 7.20 and a beta of 0.99. DocuSign has a 1 year low of $38.11 and a 1 year high of $69.45. The business’s 50 day simple moving average is $55.52 and its 200-day simple moving average is $49.18.

DocuSign (NASDAQ:DOCUGet Free Report) last issued its quarterly earnings data on Thursday, December 7th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.16. The business had revenue of $700.42 million for the quarter, compared to analysts’ expectations of $690.27 million. DocuSign had a return on equity of 14.06% and a net margin of 1.90%. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.05 EPS. On average, sell-side analysts expect that DocuSign will post 0.57 earnings per share for the current year.

About DocuSign

(Get Free Report

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Analyst Recommendations for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.